SCHEMBL13679592

SCHEMBL13679592

C1=CC2=C(CC1)OCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10157906 0.86 CA1 (0.33)
SCHEMBL14591129 0.78
SCHEMBL16511466 0.71 CA1 (0.41)
SCHEMBL3686374 0.70
SCHEMBL12186380 0.70 CA1 (0.40)
SCHEMBL16423308 0.67 ALDH1A1 (0.36)
SCHEMBL19920454 0.65 CA1 (0.30)
SCHEMBL1253233 0.65
SCHEMBL29165209 0.64
SCHEMBL313389 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102712649-A Benzimidazole derivatives and pharmaceutical compositions and uses thereof KBP BIOSCIENCES CO LTD 2012-10-03 CN disclosed
EP-1377288-B1 2,1-OXAZOLINE AND 1,2-PYRAZOLINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND USE BRISTOL MYERS SQUIBB CO (US) 2009-09-23 EP disclosed
EP-1261586-B1 CYCLOPROPYL-FUSED PYRROLIDINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV, PROCESSES FOR THEIR PREPARATION, AND THEIR USE BRISTOL MYERS SQUIBB CO (US) 2008-05-21 EP disclosed